Results: 1-25 | 26-50 | 51-75 | 76-100 | >>

Table of contents of journal: *Bone marrow transplantation

Results: 1-25/488

Authors: Frei, E Richardson, P Avigan, D Bunnell, C Wheeler, C Elias, A
Citation: E. Frei et al., The interval between courses of high-dose chemotherapy with stem cell rescue: therapeutic hypotheses, BONE MAR TR, 24(9), 1999, pp. 939-945

Authors: Worth, LL Tran, H Petropoulos, D Culbert, SC Mullen, CA Roberts, WM Przepiorka, D Chan, KW
Citation: Ll. Worth et al., Hematopoietic stem cell transplantation for childhood myeloid malignanciesafter high-dose thiotepa, busulfan and cyclophosphamide, BONE MAR TR, 24(9), 1999, pp. 947-952

Authors: Lawson, SE Williams, MD Darbyshire, PJ
Citation: Se. Lawson et al., Use of idarubicin in pre-transplant conditioning in children with high-risk acute leukaemia, BONE MAR TR, 24(9), 1999, pp. 953-958

Authors: Klein, JL Rey, PM Dansey, R Karanes, C Abella, E Cassells, L Hamm, C Flowers, M Couwlier, C Peters, WP Baynes, RD
Citation: Jl. Klein et al., Cyclophosphamide and paclitaxel as initial or salvage regimen for the mobilization of peripheral blood progenitor cells, BONE MAR TR, 24(9), 1999, pp. 959-963

Authors: Lim, FTH van Beckhoven, JM Brand, A Kluin-Nelemans, JC Hermans, JMH Willemze, R Kanhai, HHH Falkenburg, JHF
Citation: Fth. Lim et al., The number of nucleated cells reflects: the hematopoietic content of umbilical cord blood for transplantation, BONE MAR TR, 24(9), 1999, pp. 965-970

Authors: Benedetti, G Patoia, L Giglietti, A Alessio, M Pelicci, PG Grignani, F
Citation: G. Benedetti et al., Very large amounts of peripheral blood progenitor cells eliminate severe thrombocytopenia after high-dose melphalan in advanced breast cancer patients, BONE MAR TR, 24(9), 1999, pp. 971-979

Authors: Schwartzberg, LS Weaver, CH Lewkow, L McAneny, B Zhen, B Birch, R West, WH Tauer, KW Buckner, CD
Citation: Ls. Schwartzberg et al., High-dose chemotherapy with peripheral blood stem cell support for stage IIIB inflammatory carcinoma of the breast, BONE MAR TR, 24(9), 1999, pp. 981-987

Authors: Schey, SA Ahsan, G Jones, R
Citation: Sa. Schey et al., Dose intensification and molecular responses in patients with chronic lymphocytic leukaemia: a phase II single centre study, BONE MAR TR, 24(9), 1999, pp. 989-993

Authors: Kodera, Y Morishima, Y Kato, S Akiyama, Y Sao, H Matsuyama, T Kawa, K Sakamaki, H Nakagawa, S Hirabayashi, N Dohi, H Okamoto, S Hiraoka, A Gondo, H Tsuchida, M O, H Harada, M Asano, S Juji, T Sasazuki, T Takaku, F
Citation: Y. Kodera et al., Analysis of 500 bone marrow transplants from unrelated donors (UR-BMT) facilitated by the Japan Marrow Donor Program: confirmation of UR-BMT as a standard therapy for patients with leukemia and aplastic anemia, BONE MAR TR, 24(9), 1999, pp. 995-1003

Authors: Takatsuta, H Takemoto, Y Okamoto, T Fujimori, Y Tamura, S Wada, H Okada, M Yamada, S Kanamaru, A Kakishita, E
Citation: H. Takatsuta et al., Predicting the severity of graft-versus-host disease from interleukin-10 levels after bone marrow transplantation, BONE MAR TR, 24(9), 1999, pp. 1005-1007

Authors: Horn, B Viele, M Mentzer, W Mogck, N DeSantes, K Cowan, M
Citation: B. Horn et al., Autoimmune hemolytic anemia in patients with SCID after T cell-depleted BMand PBSC transplantation, BONE MAR TR, 24(9), 1999, pp. 1009-1013

Authors: Wymenga, ANM van der Graaf, WTA Kema, IP Sibinga, CTS de Vries, EGE Mulder, NH
Citation: Anm. Wymenga et al., Effects of peripheral stem cell or bone marrow reinfusion on peripheral serotonin metabolism, BONE MAR TR, 24(9), 1999, pp. 1015-1018

Authors: Venditti, A Battaglia, A Del Poeta, G Buccisano, F Maurillo, L Tamburini, A Del Moro, B Epiceno, AM Martiradonna, M Caravita, T Santinelli, S Adorno, G Picardi, A Zinno, F Lanti, A Bruno, A Suppo, G Franchi, A Franconi, G Amadori, S
Citation: A. Venditti et al., Enumeration of CD34(+) hematopoietic progenitor cells for clinical transplantation: comparison of three different methods, BONE MAR TR, 24(9), 1999, pp. 1019-1027

Authors: Vela-Ojeda, J de Leon, LD Tripp-Villanueva, F Sanchez-Cortes, E Ayala-Sanchez, M Esparza, MAGR Rosas-Cabral, A Gonzalez-Llaven, J
Citation: J. Vela-ojeda et al., Malignant fibrous histiocytoma after allogeneic bone marrow transplantation, BONE MAR TR, 24(9), 1999, pp. 1029-1031

Authors: Hentschke, P Hagglund, H Mattsson, J Carlens, S Lonnqvist, B Ljungman, P Aschan, J Fredrikson, S Ringden, O
Citation: P. Hentschke et al., Bilateral subdural haematomas following lumbar puncture in three haematopoietic stem cell transplant recipients, BONE MAR TR, 24(9), 1999, pp. 1033-1035

Authors: Navari, RM Catt, JH Siegler, M
Citation: Rm. Navari et al., A prisoner with chronic myeloid leukemia, BONE MAR TR, 24(9), 1999, pp. 1037-1039

Authors: Ferreira, E Pasternak, J Bacal, N Guerra, JCD Watanabe, FM
Citation: E. Ferreira et al., Autologous cord blood transplantation, BONE MAR TR, 24(9), 1999, pp. 1041-1041

Authors: James, RI May, C Diers, MD Wagner, JE McIvor, RS
Citation: Ri. James et al., Methotrexate resistance conferred by transplantation of drug-resistant transgenic marrow cells fractionated by counterflow elutriation, BONE MAR TR, 24(8), 1999, pp. 815-821

Authors: Remberger, M Svahn, BM Hentschke, P Lofgren, C Ringden, O
Citation: M. Remberger et al., Effect on cytokine release and graft-versus-host disease of different anti-T cell antibodies during conditioning for unrelated haematopoietic stem cell transplantation, BONE MAR TR, 24(8), 1999, pp. 823-830

Authors: Hagglund, H Ringden, O Oman, S Remberger, M Carlens, S Mattsson, J
Citation: H. Hagglund et al., A prospective randomized trial of Filgrastim (r-metHuG-CSF) given at different times after unrelated bone marrow transplantation, BONE MAR TR, 24(8), 1999, pp. 831-836

Authors: Chakraborty, NG Bilgrami, S Maness, LJ Guo, C Perez-Diez, A Mukherji, B Tutschka, P
Citation: Ng. Chakraborty et al., Myeloablative chemotherapy with autologous peripheral blood stem cell transplantation for metastatic breast cancer: immunologic consequences affecting clinical outcome, BONE MAR TR, 24(8), 1999, pp. 837-843

Authors: Herrera-Garza, JL Jaime-Perez, JC Montemayor, JL Ibarra-Peart, RE Gomez-Almaguer, D
Citation: Jl. Herrera-garza et al., High-dose peripheral blood stem cell transplant for multitransfused severeaplastic anaemia patients without antithymocyte globulin in the conditioning regimen, BONE MAR TR, 24(8), 1999, pp. 845-848

Authors: de Medeiros, CR Zanis-Neto, J Pasquini, R
Citation: Cr. De Medeiros et al., Bone marrow transplantation for patients with Fanconi anemia: reduced doses of cyclophosphamide without irradiation as conditioning, BONE MAR TR, 24(8), 1999, pp. 849-852

Authors: Saba, N Sutton, DM Ross, HJ Siu, S Crump, RM Keating, A Stewart, AK
Citation: N. Saba et al., High treatment-related mortality in cardiac amyloid patients undergoing autologous stem cell transplant, BONE MAR TR, 24(8), 1999, pp. 853-855

Authors: Dickinson, AM Hromadnikova, I Sviland, L Jackson, GH Taylor, PRA Vavrinec, J Sedlacek, P Cermakova, M Stary, J Vitek, A Sajdova, J Proctor, SJ
Citation: Am. Dickinson et al., Use of a skin explant model for predicting GVHD in HLA-matched bone marrowtransplants - effect of GVHD prophylaxis, BONE MAR TR, 24(8), 1999, pp. 857-863
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>